##fileformat=VCFv4.1
##source=VarSeqV2.5.0
##fileDate=20230918
##INFO=<ID=Type,Number=1,Type=String,Description="Type of CNV event (either Gain, Loss, or CN LoH)">
##INFO=<ID=Targets,Number=1,Type=Integer,Description="Number of targets in this event">
##INFO=<ID=Samples2,Number=1,Type=Integer,Description="Number of samples that share this event">
##INFO=<ID=Span,Number=1,Type=Integer,Description="Size of this event">
##INFO=<ID=GeneNames,Number=.,Type=String,Description="The set of unique gene names seen in all overlapping transcripts">
##INFO=<ID=GeneIDs,Number=.,Type=String,Description="The set of Entrez gene identifiers for all overlapping transcripts">
##INFO=<ID=Aliases,Number=.,Type=String,Description="Previous names for the set of genes">
##INFO=<ID=Genes,Number=1,Type=Integer,Description="The number of genes overlapping this region.">
##INFO=<ID=TranscriptNameClinicallyRelevant,Number=.,Type=String,Description="The transcript determined to be clinically relevant among those found for the variant's interaction with the gene. If the variant affects multiple genes, one transcript from each gene is selected to be clinically relevant. The clinically relevant transcript is the transcript with the longest coding sequence among the transcripts with an LRG annotation. If a gene has no transcripts that are annotated with an LRG ID, the transcript with the longest coding sequence is used. For more information on how transcripts are chosen see our <a href='http://blog.goldenhelix.com/ajesaitis/whats-in-a-name-the-intricacies-of-identifying-variants/'>blog post on the topic</a>.">
##INFO=<ID=OverlappingExonsClinicallyRelevant,Number=.,Type=String,Description="Which exons of the transcript overlapping this region, or 'All' if they all overlap. Exon numbers are always numbered from the 5' UTR to the 3' UTR.">
##INFO=<ID=HGVSg,Number=1,Type=String,Description="The associated HGVS notation using the genomic reference sequence.">
##INFO=<ID=HGVScClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS coding DNA notation with the clinically relevant transcript(s).">
##INFO=<ID=HGVSpClinicallyRelevant,Number=.,Type=String,Description="The associated HGVS protein change notation with the clinically relevant transcript(s).">
##INFO=<ID=ISCNCytobandNotation,Number=1,Type=String,Description="ISCN notation describing the overlapping cytobands.">
##INFO=<ID=SequenceOntologyClinicallyRelevant,Number=1,Type=String,Description="The sequence ontology associated with the clinically relevant transcript(s).">
##INFO=<ID=RegionClinicallyRelevant,Number=1,Type=String,Description="The region in which the variant is located. When a variant overlaps multiple regions, the region with the highest precedence is given. The order of precedence is defined as (from highest to lowest): exon, utr5, utr3, intron, intergenic.">
##INFO=<ID=Region,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span2,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Name,Number=.,Type=String,Description="DGV Gene Name">
##INFO=<ID=Frequency,Number=.,Type=Float,Description="Samples Count / Num. of Unique Samples">
##INFO=<ID=Type2,Number=1,Type=String,Description="Gain or Loss">
##INFO=<ID=Region2,Number=.,Type=String,Description="The genomic position of the region.">
##INFO=<ID=Span3,Number=.,Type=Integer,Description="The size of the region (Stop-Stop).">
##INFO=<ID=OverlapType2,Number=1,Type=String,Description="Specifies the way in which the CNV overlaps the region. Either \"Contains Region\", \"Within Region\", \"Identical\", or \"Partial Overlap\".">
##INFO=<ID=Type3,Number=1,Type=String,Description="">
##INFO=<ID=Frequency2,Number=.,Type=Float,Description="">
##INFO=<ID=DeletionFrequency,Number=.,Type=Float,Description="">
##INFO=<ID=DuplicationFrequency,Number=.,Type=Float,Description="">
##FORMAT=<ID=CNVState,Number=1,Type=String,Description="State of the CNV event for each sample">
##FORMAT=<ID=AvgTargetMeanDepth,Number=1,Type=Float,Description="Average mean depth of the targets in this event as reported by Coverage Statistics">
##FORMAT=<ID=AvgZScore,Number=1,Type=Float,Description="Average Z-score of the targets in this event">
##FORMAT=<ID=AvgRatio,Number=1,Type=Float,Description="Average ratio of the targets in this event">
##FORMAT=<ID=pvalue,Number=1,Type=Float,Description="Probability that z-scores at least as extreme as those in the event would occur by chance in a normal region.">
##FORMAT=<ID=GeneList,Number=.,Type=String,Description="The genes that the cnv overlaps">
##FORMAT=<ID=CriticalGeneList,Number=.,Type=String,Description="The critical genes that the cnvs overlaps, these genes have established evidence for HI/TS. HI/TS maybe come from genes and regions in clingen or from the internal catalog of gene evaluations.">
##FORMAT=<ID=ScoredGene,Number=.,Type=String,Description="The gene with the maximum score for the gene specific criteria from the critical gene list. This gene has the strongest known effect.">
##FORMAT=<ID=ScoredGeneTranscript,Number=.,Type=String,Description="The transcript for the gene that was scored">
##FORMAT=<ID=Classification,Number=1,Type=String,Description="Classification of the score, this catagorizes the score to it pathogenicity based on the thresholds of Benign: score <= -1, Likely Benign: -1 < score <= -0.9, VUS: -0.9 < score < 0.9, Likely Pathogenic: 0.9 <= score < 1, Pathogenic: score <= 1.">
##FORMAT=<ID=Criteria,Number=.,Type=String,Description="The list of all of the criteria that were applied to reach the 'Total Score' and as a result the 'Classification'.">
##INFO=<ID=END,Number=1,Type=Integer,Description="">
##FORMAT=<ID=GT,Number=1,Type=String,Description="">
##FORMAT=<ID=CN,Number=1,Type=Integer,Description="">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	H174-301222-ROCHE_S122_R
1	1712255	.	N	<DEL>	.	.	Type=Loss;Targets=11;Samples2=2;Span=26794;GeneNames=CDK11A,SLC35E2A;GeneIDs=728642,9906;Aliases=CDC2L2,CDC2L3,CDK11-p110,CDK11-p46,CDK11-p58,PITSLRE,p58GTA;Genes=2;TranscriptNameClinicallyRelevant=NM_024011.4,NR_173244.1;OverlappingExonsClinicallyRelevant=1-6,4-7;HGVSg=NC_000001.11:g.1712255_1739048del;HGVScClinicallyRelevant=NM_024011.4:c.1_625+9del,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(1)p36.33;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=1:1689245-1760882,1:1703766-1749003,1:1727506-1760461,1:1731499-1741164;Span2=71638,45238,32956,9666;OverlapType=Within Region,Within Region,Partial Overlap,Partial Overlap;Name=gssvL103,gssvL110,gssvL111,gssvL124;Frequency=0.0186,0.0075,0.002,0.0011;Type2=Loss,Loss,Loss,Loss;END=1739048	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:58.1265:-1.61922:0.517447:1.43968847972609e-07:CDK11A,SLC35E2A::CDK11A:NM_024011.4:Benign:2B0WhiletheCNVoverlapstheCDK11AgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37434inClinGenDosageSensitivity.,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
1	12828397	.	N	<DEL>	.	.	Type=Loss;Targets=10;Samples2=1;Span=55088;GeneNames=HNRNPCL1,PRAMEF2,PRAMEF4,PRAMEF11;GeneIDs=440560,343069,65122,400735;Genes=4;TranscriptNameClinicallyRelevant=NM_001013631.3,NM_023014.1,NM_001009611.4,NM_001146344.3;OverlappingExonsClinicallyRelevant=All,All,2-4,1-2;HGVSg=NC_000001.11:g.12828397_12883484del;HGVScClinicallyRelevant=.,.,.,NM_001146344.3:c.1_293+100del;HGVSpClinicallyRelevant=.,.,.,.;ISCNCytobandNotation=del(1)p36.21;SequenceOntologyClinicallyRelevant=.,.,.,transcript_ablation;RegionClinicallyRelevant=.,.,.,exon;Region=1:12774425-12867713,1:12775725-12987188,1:12818031-12903935,1:12834668-12868975,1:12848979-12903944,1:12849384-12868003,1:12849386-12861257,1:12850124-12989284;Span2=93289,211464,85905,34308,54966,18620,11872,139161;OverlapType=Partial Overlap,Within Region,Within Region,Contains Region,Partial Overlap,Contains Region,Contains Region,Partial Overlap;Name=gssvL888,gssvL883,gssvL891,gssvL905,gssvL894,gssvL920,gssvL929,gssvL886;Frequency=0.0215,0.0153,0.0652,0.0927,0.0017,0.0139,0.0023,0.0155;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=1:12793717-12859204;Span3=65488;OverlapType2=Partial Overlap;Type3=Deletion;Frequency2=0.0364693;DeletionFrequency=0.0364693;DuplicationFrequency=0;END=12883484	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:126.994:-1.7254:0.609131:9.06707832621016e-08:HNRNPCL1,PRAMEF2,PRAMEF4,PRAMEF11::HNRNPCL1:NM_001013631.3:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46309inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
1	16567937	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=1;Span=11505;GeneNames=NBPF1;GeneIDs=55672;Aliases=AB13,AB14,AB23,AD2,NBG,NBPF;Genes=1;TranscriptNameClinicallyRelevant=NM_017940.6;OverlappingExonsClinicallyRelevant=17-24;HGVSg=NC_000001.11:g.16567937_16579441dup;HGVScClinicallyRelevant=NM_017940.6:c.1592-39_2666+42dup;HGVSpClinicallyRelevant=NP_060410.3:p.R889Sfs*73;ISCNCytobandNotation=dup(1)p36.13;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;Region=1:16563917-16594366;Span2=30450;OverlapType=Within Region;Name=gssvG509;Frequency=1;Type2=Gain;END=16579441	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:349.771:1.50539:1.43761:0.000102365247655896:NBPF1::NBPF1:NM_017940.6:VUS:2L0ThiscnvpartiallyoverlapstheNBPF1genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	78119387	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=1;Span=6594;GeneNames=GIPC2;GeneIDs=54810;Aliases=SEMCAP-2,SEMCAP2;Genes=1;TranscriptNameClinicallyRelevant=NM_017655.6;OverlappingExonsClinicallyRelevant=4-5;HGVSg=NC_000001.11:g.78119387_78125980dup;HGVScClinicallyRelevant=NM_017655.6:c.608-6_796+18dup;HGVSpClinicallyRelevant=NP_060125.4:p.E203_L265dup;ISCNCytobandNotation=dup(1)p31.1;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=78125980	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:87.2042:3.25939:1.47318:6.64324185311138e-06:GIPC2::GIPC2:NM_017655.6:VUS:2L0ThiscnvpartiallyoverlapstheGIPC2genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
1	147986186	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=1;Span=6770;GeneNames=GPR89B;GeneIDs=51463;Aliases=GPHR,GPR89,GPR89C,SH120,UNQ192;Genes=1;TranscriptNameClinicallyRelevant=NM_016334.5;OverlappingExonsClinicallyRelevant=11-14;HGVSg=NC_000001.11:g.147986186_147992955del;HGVScClinicallyRelevant=NM_016334.5:c.910-13_1368del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(1)q21.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=147992955	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:29.0407:-2.58287:0.516223:4.25758409837701e-07:GPR89B::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
2	112370125	.	N	<DEL>	.	.	Type=Loss;Targets=4;Samples2=3;Span=20162;GeneNames=RGPD8;GeneIDs=727851;Aliases=RANBP2L1,RGP8,RanBP2alpha;Genes=1;TranscriptNameClinicallyRelevant=NM_001164463.1;OverlappingExonsClinicallyRelevant=20-23;HGVSg=NC_000002.12:g.112370125_112390286del;HGVScClinicallyRelevant=NM_001164463.1:c.2698-39_5298del;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=del(2)q14.1;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;END=112390286	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:34.8043:-2.00173:0.453894:9.20740633936917e-05:RGPD8::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
5	69567693	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=10;Span=4877;GeneNames=GTF2H2C;GeneIDs=728340;Aliases=GTF2H2C_2;Genes=1;TranscriptNameClinicallyRelevant=NM_001376000.2;OverlappingExonsClinicallyRelevant=7-9;HGVSg=NC_000005.10:g.69567693_69572569dup;HGVScClinicallyRelevant=NM_001376000.2:c.259-34_470+19dup;HGVSpClinicallyRelevant=NP_001362929.1:p.K157Nfs*7;ISCNCytobandNotation=dup(5)q13.2;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=69572569	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:165.933:5.00481:2.03813:4.06065435138075e-12:GTF2H2C::GTF2H2C:NM_001376000.2:Benign:2L0ThiscnvpartiallyoverlapstheGTF2H2Cgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
5	71002057	.	N	<DUP>	.	.	Type=Gain;Targets=3;Samples2=2;Span=10868;GeneNames=NAIP;GeneIDs=4671;Aliases=BIRC1,NLRB1,psiNAIP;Genes=1;TranscriptNameClinicallyRelevant=NM_004536.3;OverlappingExonsClinicallyRelevant=4-7;HGVSg=NC_000005.10:g.71002057_71012924dup;HGVScClinicallyRelevant=NM_004536.3:c.1_802+35dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(5)q13.2;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=5:70979954-71009954,5:71002908-71009954,5:71008437-71017475;Span2=30001,7047,9039;OverlapType=Partial Overlap,Contains Region,Partial Overlap;Name=gssvG30125,gssvG30195,gssvG30200;Frequency=0.275,0.0299,0.2152;Type2=Gain,Gain,Gain;Region2=5:71004950-71008994;Span3=4045;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.025;DeletionFrequency=0;DuplicationFrequency=0.025;END=71012924	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:162.43:2.3475:1.49141:7.24585703746077e-05:NAIP::NAIP:NM_004536.3:Benign:2L0ThiscnvpartiallyoverlapstheNAIPgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
10	47474291	.	N	<DEL>	.	.	Type=Loss;Targets=21;Samples2=1;Span=288723;GeneNames=AGAP9,ANXA8,BMS1P2,BMS1P2-AGAP9,CTSLP2,FAM25G,LOC102724593,SHLD2P3,SYT15B;GeneIDs=653145,100133093,113939912,642517,642826,1517,439965,102724593,102724488;Aliases=ANX8,CH17-360D5.2;Genes=9;TranscriptNameClinicallyRelevant=NM_001190810.1,NM_001040084.3,NR_024495.2,NR_160415.1,NR_033407.1,NM_001137549.2,NR_134489.1,NR_160661.1,NM_001370184.1;OverlappingExonsClinicallyRelevant=All,1-8,All,All,All,All,All,All,All;HGVSg=NC_000010.11:g.47474291_47763013del;HGVScClinicallyRelevant=.,NM_001040084.3:c.1_646+14del,.,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.,.,.;ISCNCytobandNotation=del(10)q11.22;SequenceOntologyClinicallyRelevant=.,transcript_ablation,.,.,.,.,.,.,.;RegionClinicallyRelevant=.,exon,.,.,.,.,.,.,.;Region=10:47075775-47775197,10:47599162-47696561,10:47627616-48013262;Span2=699423,97400,385647;OverlapType=Within Region,Contains Region,Partial Overlap;Name=gssvL12088,gssvL12124,gssvL12094;Frequency=0.0066,0.1194,0.0034;Type2=Loss,Loss,Loss;Region2=10:47514278-47585576;Span3=71299;OverlapType2=Contains Region;Type3=Deletion;Frequency2=0.102008;DeletionFrequency=0.102008;DuplicationFrequency=0;END=47763013	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:25.5344:-2.1366:0.310149:7.36807034571316e-22:AGAP9,ANXA8,BMS1P2,BMS1P2-AGAP9,CTSLP2,FAM25G,LOC102724593,SHLD2P3,SYT15B::AGAP9:NM_001190810.1:Benign:2G0TheCNVisoverlapsthehaplobenignregionISCA-46443inClinGenDosageSensitivitybutincludesadditionalmaterial.,3A0Thiscnvoverlaps4proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
11	55603432	.	N	<DEL>	.	.	Type=Loss;Targets=3;Samples2=8;Span=48417;GeneNames=OR4C11,OR4P4,OR4S2;GeneIDs=219429,81300,219431;Aliases=OR11-136,OR4C11P;Genes=3;TranscriptNameClinicallyRelevant=NM_001004700.3,NM_001004124.2,NM_001004059.3;OverlappingExonsClinicallyRelevant=All,All,All;HGVSg=NC_000011.10:g.55603432_55651848del;HGVScClinicallyRelevant=.,.,.;HGVSpClinicallyRelevant=.,.,.;ISCNCytobandNotation=del(11)q11;SequenceOntologyClinicallyRelevant=.,.,.;RegionClinicallyRelevant=.,.,.;Region=11:55584048-55662960,11:55590444-55759159,11:55591984-55702527,11:55593873-55619297,11:55593873-55636296,11:55612468-55663948,11:55618180-55695666,11:55628565-55653563,11:55635325-55667703;Span2=78913,168716,110544,25425,42424,51481,77487,24999,32379;OverlapType=Within Region,Within Region,Within Region,Partial Overlap,Partial Overlap,Partial Overlap,Partial Overlap,Partial Overlap,Partial Overlap;Name=gssvL19011,gssvL19000,gssvL19002,gssvL19027,gssvL19018,gssvL19013,gssvL19010,gssvL19035,gssvL19023;Frequency=0.0269,0.0006,0.1602,0.0005,0.0012,0.0012,0.0277,0.0029,0.0063;Type2=Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss,Loss;Region2=11:55473540-55654863,11:55597202-55685585,11:55597354-55684660,11:55597959-55664091,11:55606557-55682976;Span3=181324,88384,87307,66133,76420;OverlapType2=Within Region,Within Region,Within Region,Within Region,Partial Overlap;Type3=Deletion,Deletion,Deletion,Deletion,Deletion;Frequency2=0.000337895,0.442222,0.4,0.28277,0.452948;DeletionFrequency=0.000337895,0.442222,0.4,0.28277,0.452948;DuplicationFrequency=0,0,0,0,0;END=55651848	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-2.25175:0:0.000139985310251864:OR4C11,OR4P4,OR4S2::OR4C11:NM_001004700.3:Benign:2F-1ThecnviscompletelycontainedinthehaplobenignregionISCA-46458inClinGenDosageSensitivity.,3A0Thiscnvoverlaps3proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:0
14	106410434	.	N	<DUP>	.	.	Type=Gain;Targets=2;Samples2=3;Span=568;END=106411001	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:314.885:4.01393:1.44683:2.75643387648251e-08:::.:.:Benign:1B-0.6TheCNVdoesnotoverlapanygenes,2D-1ThecnvissmallerthanthetriplobenignregionISCA-37477inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps0proteincodinggenes:3
15	43596409	.	N	<DUP>	.	.	Type=Gain;Targets=1;Samples2=1;Span=120;GeneNames=CKMT1B;GeneIDs=1159;Aliases=CKMT,CKMT1,UMTCK;Genes=1;TranscriptNameClinicallyRelevant=NM_001375484.1;OverlappingExonsClinicallyRelevant=6;HGVSg=NC_000015.10:g.43596409_43596528dup;HGVScClinicallyRelevant=NM_001375484.1:c.753_754ins(120);HGVSpClinicallyRelevant=NP_001362413.1:p.H252_K291dup;ISCNCytobandNotation=dup(15)q15.3;SequenceOntologyClinicallyRelevant=inframe_insertion;RegionClinicallyRelevant=exon;END=43596528	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:148.525:3.80158:1.74168:0.000209217595290923:CKMT1B::CKMT1B:NM_001375484.1:Benign:2L0ThiscnvpartiallyoverlapstheCKMT1Bgenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
16	2106796	.	N	<DEL>	.	.	Type=Loss;Targets=1;Samples2=1;Span=162;GeneNames=PKD1;GeneIDs=5310;Aliases=PBP,PC1,Pc-1,TRPP1;Genes=1;TranscriptNameClinicallyRelevant=NM_001009944.3;OverlappingExonsClinicallyRelevant=17;HGVSg=NC_000016.10:g.2106796_2106957del;HGVScClinicallyRelevant=NM_001009944.3:c.7066-9_7209+9del;HGVSpClinicallyRelevant=NP_001009944.3:p.V2356_G2403del;ISCNCytobandNotation=del(16)p13.3;SequenceOntologyClinicallyRelevant=inframe_deletion;RegionClinicallyRelevant=exon;END=2106957	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:28.2346:-4.20231:0.235042:4.02859930196333e-05:PKD1:PKD1:PKD1:NM_001009944.3:VUS:2E0.45BothbreakpointsarewithinthePKD1geneandthereisatleastonedownstreampathogenicvariantresultinginaInframeDeletionmutationwithaPVS1STRONGclassification,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:1
17	16761416	.	N	<DUP>	.	.	Type=Gain;Targets=10;Samples2=2;Span=177821;GeneNames=CCDC144A,FAM106C,KRT16P2,KRT17P1,TBC1D27P,TNFRSF13B,USP32P1;GeneIDs=9720,162632,100129396,400578,147228,96597,23495;Genes=7;TranscriptNameClinicallyRelevant=NM_001382000.1,NR_170993.1,NR_029392.1,NR_146392.1,NR_147084.1,NM_012452.3,NR_003190.2;OverlappingExonsClinicallyRelevant=13-17,All,All,All,All,5,All;HGVSg=NC_000017.11:g.16761416_16939236dup;HGVScClinicallyRelevant=NM_001382000.1:c.3373-9_4278dup,.,.,.,.,.,.;HGVSpClinicallyRelevant=.,.,.,.,.,.,.;ISCNCytobandNotation=dup(17)p11.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.,.,.,.,.,.;RegionClinicallyRelevant=exon,.,.,.,.,.,.;Region=17:16753287-16820986,17:16814141-16874492;Span2=67700,60352;OverlapType=Partial Overlap,Contains Region;Name=gssvG16012,gssvG16013;Frequency=0.4635,0.275;Type2=Gain,Gain;Region2=17:16814709-16854081;Span3=39373;OverlapType2=Contains Region;Type3=Duplication;Frequency2=0.00118343;DeletionFrequency=0;DuplicationFrequency=0.00118343;END=16939236	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:159.959:1.87092:1.37721:7.02710438339632e-09:CCDC144A,FAM106C,KRT16P2,KRT17P1,TBC1D27P,TNFRSF13B,USP32P1::CCDC144A:NM_001382000.1:VUS:2B0WhiletheCNVoverlapstheCCDC144AgeneitisunclearifthisisthecausativegeneforhaploinsufficientregionISCA-37418inClinGenDosageSensitivity.,2G0TheCNVisoverlapsthetriplobenignregionISCA-46702inClinGenDosageSensitivitybutincludesadditionalmaterial.,2L0ThiscnvpartiallyoverlapstheCCDC144Agenewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps2proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	14397068	.	N	<DEL>	.	.	Type=Loss;Targets=2;Samples2=1;Span=876;GeneNames=ADGRE5;GeneIDs=976;Aliases=CD97,TM7LN1;Genes=1;TranscriptNameClinicallyRelevant=NM_078481.4;OverlappingExonsClinicallyRelevant=6-8;HGVSg=NC_000019.10:g.14397068_14397943del;HGVScClinicallyRelevant=NM_078481.4:c.479-9_819+8del;HGVSpClinicallyRelevant=NP_510966.1:p.V161Afs*33;ISCNCytobandNotation=del(19)p13.12;SequenceOntologyClinicallyRelevant=frameshift_variant;RegionClinicallyRelevant=exon;END=14397943	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:HetDeletion:42.6911:-3.68599:0.456511:3.34944720226644e-07:ADGRE5::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps1proteincodinggenes:1
19	43066523	.	N	<DUP>	.	.	Type=Gain;Targets=5;Samples2=1;Span=16095;GeneNames=PSG2;GeneIDs=5670;Aliases=CEA,PSBG2;Genes=1;TranscriptNameClinicallyRelevant=NM_031246.4;OverlappingExonsClinicallyRelevant=1-5;HGVSg=NC_000019.10:g.43066523_43082617dup;HGVScClinicallyRelevant=.;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.31;SequenceOntologyClinicallyRelevant=.;RegionClinicallyRelevant=.;END=43082617	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:363.346:3.19821:1.3339:2.4451159799017e-12:PSG2::PSG2:NM_031246.4:Benign:2D-1ThecnvissmallerthanthetriplobenignregionISCA-37483inClinGenDosageSensitivityanddoesnotinteruptanyprotiencodinggenes,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene:3
19	54240273	.	N	<DUP>	.	.	Type=Gain;Targets=7;Samples2=6;Span=2522;GeneNames=LILRA6;GeneIDs=79168;Aliases=CD85b,ILT-8,ILT5,ILT8,LILRB6;Genes=1;TranscriptNameClinicallyRelevant=NM_024318.4;OverlappingExonsClinicallyRelevant=1-6;HGVSg=NC_000019.10:g.54240273_54242794dup;HGVScClinicallyRelevant=NM_024318.4:c.1_1258+1dup;HGVSpClinicallyRelevant=.;ISCNCytobandNotation=dup(19)q13.42;SequenceOntologyClinicallyRelevant=transcript_ablation;RegionClinicallyRelevant=exon;Region=19:54235621-54244614;Span2=8994;OverlapType=Within Region;Name=gssvG19405;Frequency=0.1558;Type2=Gain;Region2=19:54234062-54243168,19:54235622-54243993;Span3=9107,8372;OverlapType2=Within Region,Within Region;Type3=Duplication,Duplication;Frequency2=0.00118343,0.025;DeletionFrequency=0,0;DuplicationFrequency=0.00118343,0.025;END=54242794	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:331.01:1.59146:1.71954:3.95985350978714e-05:LILRA6::LILRA6:NM_024318.4:Benign:2L0ThiscnvpartiallyoverlapstheLILRA6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
21	5117108	.	N	<DEL>	.	.	Type=Loss;Targets=12;Samples2=4;Span=35969;GeneNames=LOC102724023,LOC102724159;GeneIDs=102724023,102724159;Aliases=GATD3B,KNP-I;Genes=2;TranscriptNameClinicallyRelevant=NM_001363758.2,NM_001368238.1;OverlappingExonsClinicallyRelevant=All,2-21;HGVSg=NC_000021.9:g.5117108_5153076del;HGVScClinicallyRelevant=NM_001363758.2:c.1_802del,NM_001368238.1:c.19-3_2760del;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=del(21)p12;SequenceOntologyClinicallyRelevant=transcript_ablation,transcript_ablation;RegionClinicallyRelevant=exon,exon;END=5153076	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Deletion:0:-1.44774:0:9.09260347079643e-07:LOC102724023,LOC102724159::.:.:VUS:1A0TheCNVoverlapsthecodingregionofatleastonegene,3A0Thiscnvoverlaps2proteincodinggenes:0
22	42130603	.	N	<DUP>	.	.	Type=Gain;Targets=9;Samples2=2;Span=13865;GeneNames=CYP2D6,CYP2D7;GeneIDs=1565,1564;Aliases=CPD6,CYP2D,CYP2D7AP,CYP2D7BP,CYP2D7P2,CYP2D8P2,CYP2DL1,CYPIID6,P450-DB1,P450C2D,P450DB1;Genes=2;TranscriptNameClinicallyRelevant=NM_000106.6,NR_145674.3;OverlappingExonsClinicallyRelevant=1,All;HGVSg=NC_000022.11:g.42130603_42144467dup;HGVScClinicallyRelevant=NM_000106.6:c.1_180+9dup,.;HGVSpClinicallyRelevant=.,.;ISCNCytobandNotation=dup(22)q13.2;SequenceOntologyClinicallyRelevant=transcript_ablation,.;RegionClinicallyRelevant=exon,.;Region=22:42118886-42154516,22:42124870-42138033;Span2=35631,13164;OverlapType=Within Region,Partial Overlap;Name=gssvG24663,gssvG24665;Frequency=0.0142,0.2232;Type2=Gain,Gain;END=42144467	GT:CNVState:AvgTargetMeanDepth:AvgZScore:AvgRatio:pvalue:GeneList:CriticalGeneList:ScoredGene:ScoredGeneTranscript:Classification:Criteria:CN	0/1:Duplicate:208.705:2.8463:1.31534:5.78888289748935e-17:CYP2D6,CYP2D7::CYP2D6:NM_000106.6:Benign:2L0ThiscnvpartiallyoverlapstheCYP2D6genewhichhasunknownclinicalsignificance,3A0Thiscnvoverlaps1proteincodinggenes,1A0TheCNVoverlapsthecodingregionofatleastonegene,4O-1EverycodingregionofthecnviscontainedbyahighfrequencyregioninoneofthehighfrequencyregiontracksgnomAD-Benign-RegionsDGVGoldStandardCNVs.:3
